John Clark

John Clark is the CEO and Founder of Global Cancer Technology, a role held since January 2017. Clark has pioneered several initiatives, including the establishment of subsidiaries such as NanoMed Tracking and NanoDrug Transport, both focused on innovative cancer treatment technologies. Additionally, Clark served as Treasurer on the Palomar Health Board of Directors from December 2018 to January 2021, where responsibilities included overseeing financial affairs and advising on strategy and fundraising. Clark holds a Bachelor of Science in Pre-Med from the University of Scranton.